DexCom (DXCM) News Today $72.90 -2.42 (-3.21%) As of 02:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With DexcomMarch 25 at 11:50 AM | businesswire.comZevenbergen Capital Investments LLC Increases Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Zevenbergen Capital Investments LLC boosted its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 9.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 387,168 shares of the medical device company's stock after acquiring an additional 34,020 sMarch 25 at 7:32 AM | marketbeat.comCongress Wealth Management LLC DE Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM)Congress Wealth Management LLC DE boosted its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 865.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 169,338 shares of the medical device company's sMarch 25 at 5:05 AM | marketbeat.comVanguard Group Inc. Has $3.62 Billion Stake in DexCom, Inc. (NASDAQ:DXCM)Vanguard Group Inc. cut its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 1.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,530,017 shares of the medical device company's stock afMarch 25 at 5:04 AM | marketbeat.comKLP Kapitalforvaltning AS Invests $10.48 Million in DexCom, Inc. (NASDAQ:DXCM)KLP Kapitalforvaltning AS purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 134,700 shares of the medical device company's stock, valuedMarch 25 at 4:48 AM | marketbeat.comQuantbot Technologies LP Sells 108,680 Shares of DexCom, Inc. (NASDAQ:DXCM)Quantbot Technologies LP cut its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 84.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,002 shares of the medical device company's stock after selling 108March 25 at 4:30 AM | marketbeat.comDexCom (DXCM): 3 Reasons We Love This StockMarch 24 at 1:56 PM | msn.comSimplify Asset Management Inc. Purchases Shares of 105,405 DexCom, Inc. (NASDAQ:DXCM)Simplify Asset Management Inc. acquired a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 105,405 shares of the medical device company's stock, valueMarch 24 at 6:18 AM | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Cuts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor ownedMarch 24 at 4:49 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Receives Average Rating of "Moderate Buy" from BrokeragesDexCom, Inc. (NASDAQ:DXCM - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eighteen analysts that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, thirteen have assigned a buy recommendMarch 24 at 2:23 AM | marketbeat.comRoyal London Asset Management Ltd. Grows Position in DexCom, Inc. (NASDAQ:DXCM)Royal London Asset Management Ltd. raised its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 170,949 shares of the medical device company'sMarch 23 at 4:33 AM | marketbeat.comEnvestnet Portfolio Solutions Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM)Envestnet Portfolio Solutions Inc. raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 30.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 16,159 shares of the medical device company's stock after buying an additional 3,778 sharesMarch 23 at 3:44 AM | marketbeat.comiA Global Asset Management Inc. Sells 3,818 Shares of DexCom, Inc. (NASDAQ:DXCM)iA Global Asset Management Inc. trimmed its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 7.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 44,280 shares of the medical device company's stoMarch 22 at 5:21 AM | marketbeat.com13,207 Shares in DexCom, Inc. (NASDAQ:DXCM) Acquired by Vinva Investment Management LtdVinva Investment Management Ltd bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 13,207 shares of the medicalMarch 22 at 5:02 AM | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Increases Holdings in DexCom, Inc. (NASDAQ:DXCM)OVERSEA CHINESE BANKING Corp Ltd lifted its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 107.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,855 shares of the medical device company's stock after purchasing an additional 3,558 sharesMarch 22 at 4:53 AM | marketbeat.comGenerali Asset Management SPA SGR Makes New $1.18 Million Investment in DexCom, Inc. (NASDAQ:DXCM)Generali Asset Management SPA SGR purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 15,111 shares of the medical device compaMarch 22 at 4:37 AM | marketbeat.comThrivent Financial for Lutherans Decreases Holdings in DexCom, Inc. (NASDAQ:DXCM)Thrivent Financial for Lutherans reduced its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 10.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 281,400 shares of the medical device company's sMarch 22 at 4:27 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Sold by Kampmann Melissa S.Kampmann Melissa S. reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 19.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,335 shares of the medical device company's stock after selling 7,9March 21, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Position Boosted by Harvest Fund Management Co. LtdHarvest Fund Management Co. Ltd lifted its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 42.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 26,307 shares of the medical device company's stock after purchasing an additional 7,848March 21, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Director Bridgette P. Heller Sells 352 SharesDexCom, Inc. (NASDAQ:DXCM - Get Free Report) Director Bridgette P. Heller sold 352 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $70.33, for a total transaction of $24,756.16. Following the completion of the transaction, the director now directly owns 22,997 shares of the company's stock, valued at $1,617,379.01. This represents a 1.51 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.March 20, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Bought by Cibc World Markets CorpCibc World Markets Corp raised its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 12.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 70,763 shares of the medical device companMarch 20, 2025 | marketbeat.comIntech Investment Management LLC Grows Position in DexCom, Inc. (NASDAQ:DXCM)Intech Investment Management LLC grew its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 60.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 622,788 shares of the medical device companyMarch 19, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Natixis Advisors LLCNatixis Advisors LLC lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 446.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 193,532 shares of the medical device company's stock afterMarch 19, 2025 | marketbeat.comDexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 CareMarch 19, 2025 | businesswire.comDexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to BillionairesMarch 18, 2025 | msn.comWealthfront Advisers LLC Sells 19,083 Shares of DexCom, Inc. (NASDAQ:DXCM)Wealthfront Advisers LLC cut its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 94.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,195 shares of the medical device company's stock after selling 19,083 shares durMarch 18, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Patten & Patten Inc. TNPatten & Patten Inc. TN lifted its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 5.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 74,811 shares of the medical device company's stock after purchasing an additional 3,570March 17, 2025 | marketbeat.com74,737 Shares in DexCom, Inc. (NASDAQ:DXCM) Bought by Proficio Capital Partners LLCProficio Capital Partners LLC purchased a new stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 74,737 shares of the medical device company's stockMarch 17, 2025 | marketbeat.comCatalyst Funds Management Pty Ltd Buys Shares of 10,200 DexCom, Inc. (NASDAQ:DXCM)Catalyst Funds Management Pty Ltd bought a new stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 10,200 shares of the medical device company's stocMarch 16, 2025 | marketbeat.comAchmea Investment Management B.V. Cuts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Achmea Investment Management B.V. reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 63.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,905 shares of the medical device compMarch 16, 2025 | marketbeat.comSwiss National Bank Sells 48,400 Shares of DexCom, Inc. (NASDAQ:DXCM)Swiss National Bank decreased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,132,000 shares of the medical device company's stock after selling 48,400 shares during the period. SwiMarch 16, 2025 | marketbeat.comGreat Lakes Advisors LLC Makes New $3.43 Million Investment in DexCom, Inc. (NASDAQ:DXCM)Great Lakes Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 44,048 shares of the medical device company'sMarch 16, 2025 | marketbeat.com7,703 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by AGF Management Ltd.AGF Management Ltd. bought a new position in DexCom, Inc. (NASDAQ:DXCM - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 7,703 shares of the medical device company's stock, valued at approximately $599,000. Other instiMarch 16, 2025 | marketbeat.comMichael Jon Brown Sells 13,000 Shares of DexCom, Inc. (NASDAQ:DXCM) StockDexCom, Inc. (NASDAQ:DXCM - Get Free Report) EVP Michael Jon Brown sold 13,000 shares of the stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $70.38, for a total transaction of $914,940.00. Following the completion of the sale, the executive vice president now directly owns 105,602 shares of the company's stock, valued at $7,432,268.76. This trade represents a 10.96 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.March 15, 2025 | marketbeat.comJacob Steven Leach Sells 14,076 Shares of DexCom, Inc. (NASDAQ:DXCM) StockDexCom, Inc. (NASDAQ:DXCM - Get Free Report) COO Jacob Steven Leach sold 14,076 shares of the business's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $70.38, for a total value of $990,668.88. Following the transaction, the chief operating officer now directly owns 313,497 shares in the company, valued at $22,063,918.86. This trade represents a 4.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.March 15, 2025 | marketbeat.comInsider Selling: DexCom, Inc. (NASDAQ:DXCM) CEO Sells 32,498 Shares of StockDexCom, Inc. (NASDAQ:DXCM - Get Free Report) CEO Kevin R. Sayer sold 32,498 shares of the business's stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $70.38, for a total value of $2,287,209.24. Following the completion of the sale, the chief executive officer now owns 372,029 shares in the company, valued at approximately $26,183,401.02. This trade represents a 8.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.March 15, 2025 | marketbeat.comNearly a third of FDA medical device adverse events reported late: studyMarch 15, 2025 | msn.comInsider Selling: DexCom, Inc. (NASDAQ:DXCM) EVP Sells 13,000 Shares of StockMarch 15, 2025 | insidertrades.comLbp Am Sa Acquires 10,320 Shares of DexCom, Inc. (NASDAQ:DXCM)Lbp Am Sa boosted its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 215,810 shares of the medical device company's stock after acquirinMarch 15, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Grows Stock Position in DexCom, Inc. (NASDAQ:DXCM)Skandinaviska Enskilda Banken AB publ raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 3.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 283,654 shares of the medical device company's stock after buying an additional 9,668 sharMarch 15, 2025 | marketbeat.comAssetmark Inc. Sells 38,408 Shares of DexCom, Inc. (NASDAQ:DXCM)Assetmark Inc. trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 96.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,323 shares of the medical device company's stock after selMarch 15, 2025 | marketbeat.comPNC Financial Services Group Inc. Has $3.63 Million Stock Position in DexCom, Inc. (NASDAQ:DXCM)PNC Financial Services Group Inc. lifted its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 21.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 46,669 shares of the medical device company's stock afterMarch 14, 2025 | marketbeat.comDaiwa Securities Group Inc. Grows Holdings in DexCom, Inc. (NASDAQ:DXCM)Daiwa Securities Group Inc. grew its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 80,979 shares of the medical device company's stock after buying anMarch 13, 2025 | marketbeat.comInsider Selling: DexCom, Inc. (NASDAQ:DXCM) EVP Sells 7,000 Shares of StockDexCom, Inc. (NASDAQ:DXCM - Get Free Report) EVP Jereme M. Sylvain sold 7,000 shares of the stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $73.83, for a total transaction of $516,810.00. Following the transaction, the executive vice president now owns 135,482 shares of the company's stock, valued at $10,002,636.06. This represents a 4.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 12, 2025 | marketbeat.comWilliam Blair Predicts DexCom's Q1 Earnings (NASDAQ:DXCM)DexCom, Inc. (NASDAQ:DXCM - Free Report) - William Blair decreased their Q1 2025 earnings per share (EPS) estimates for DexCom in a report released on Monday, March 10th. William Blair analyst M. Andrew now forecasts that the medical device company will earn $0.33 per share for the quarter, downMarch 12, 2025 | marketbeat.comJereme M. Sylvain Sells 7,000 Shares of DexCom, Inc. (NASDAQ:DXCM) StockMarch 12, 2025 | insidertrades.comKing Luther Capital Management Corp Has $17.28 Million Stock Position in DexCom, Inc. (NASDAQ:DXCM)King Luther Capital Management Corp boosted its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 222,132 shares of the medical device company'March 12, 2025 | marketbeat.comAlphaQuest LLC Has $635,000 Holdings in DexCom, Inc. (NASDAQ:DXCM)AlphaQuest LLC lifted its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 428.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,165 shares of the medical device company's stock after acquirinMarch 12, 2025 | marketbeat.comEdgestream Partners L.P. Invests $1.01 Million in DexCom, Inc. (NASDAQ:DXCM)Edgestream Partners L.P. purchased a new stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,041 shares of the medical device companyMarch 12, 2025 | marketbeat.com2DXCM : DexCom Options Trading: A Deep Dive into Market SentimentMarch 11, 2025 | benzinga.com Remove Ads Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Email Address DXCM Media Mentions By Week DXCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXCM News Sentiment▼1.330.63▲Average Medical News Sentiment DXCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXCM Articles This Week▼2522▲DXCM Articles Average Week Remove Ads Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Medtronic News Today Becton, Dickinson and Company News Today Edwards Lifesciences News Today IDEXX Laboratories News Today ResMed News Today STERIS News Today Insulet News Today Baxter International News Today Hologic News Today Globus Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DXCM) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.